Search results for "Ulipristal"
showing 5 items of 5 documents
Ulipristal acetate versus leuprolide acetate for uterine fibroids
2012
A b s t r ac t Background The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear. Methods In this double-blind noninferiority trial, we randomly assigned 307 patients with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy with oral ulipristal acetate (at a dose of either 5 mg or 10 mg) or once-monthly intramuscular injections of leuprolide acetate (at a dose of 3.75 mg). The primary outcome was the proportion of patients with controlled bleeding at week 13, with a prespecified noninferiority margin of −20%. Results Uterine bleed…
Cystic degeneration of uterine leiomyoma during ulipristal acetate treatment
2016
Degenerative cyst formation is a rare phenomenon in-between uterine leiomyomas, however, both patients and physicians have to be aware of this possibility when using ullipristal acetate as this event may guide to the inaccurate diagnosis of an adnexal malignant pathology.
Medicine among métis, phrónesis and téchne
2010
Cosi come si presenta la pillola del giorno dopo puo essere utilizzata in modo efficace fino a 72 ore dopo il rapporto sessuale non protetto. Tuttavia, in alcuni casi, questo periodo puo essere troppo breve. Per tale motivo, e stata commercializzata per la prima volta una pillola, l’acetato ulipristal (Ellaone), per la contraccezione d’emergenza post-coitale fino a 120 ore (5 giorni) dopo i rapporti sessuali non protetti o nel caso di insuccesso del contraccettivo. Un aspetto importante da considerare nella valutazione etica di un farmaco usato per la contraccezione d’emergenza e il suo meccanismo d’azione, in quanto tale valutazione sara molto diversa se il farmaco agisce inibendo o ritard…
Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study
2020
Objective: This study aimed to analyze the effects of a six-month therapy with ulipristal acetate (UPA) on myoma size and endometrial thickness in premenopausal women. Material and methods: Seventy-four women undergoing conservative therapy with UPA were enrolled for this study. All women underwent transvaginal ultrasound evaluation to assess the endometrial thickness, and the number and size of myomas at the beginning and after six months. Hysteroscopy and biopsy were performed after six months, if necessary. Results: After six months of treatment, sonographic examination showed a statistically significant (p <.05) reduction of the size of the largest myoma (56.3 ± 5.1 vs. 31.7 ± 10.1 m…